
Amplyx Pharmaceuticals
https://amplyx.com/Developing a novel class of drugs to treat life‐threatening systemic fungal infections.
Total raised: $207.7M
Investors 8
Funding Rounds 5
Date | Series | Amount | Investors | Deal News |
19.05.2020 | Series C | $90M | - | connect.or... |
02.08.2017 | Series C | $67M | New Enterp... | citybizlis... |
09.02.2016 | - | $8.7M | - | finsmes.co... |
11.11.2015 | Series B | $40.5M | - | finsmes.co... |
09.04.2010 | - | $1.5M | - | sdbj.com/n... |
Mentions in press and media 160
Date | Title | Description | Category | Author | Source |
03.12.2020 | Amplyx Ann... | SAN DIEGO, Dec. 3, 2020 /PRN... | - | - | prnewswire... |
06.11.2020 | Covid-19 r... | A major player trying to ad... | - | Max Gelman... | endpts.com... |
20.05.2020 | Amplyx clo... | - | - | - | arixbiosci... |
19.05.2020 | Immune The... | - | - | - | connect.or... |
19.05.2020 | Immune The... | - | - | - | connect.or... |
19.05.2020 | Immune The... | - | - | - | connect.or... |
19.05.2020 | Immune The... | - | - | - | connect.or... |
19.05.2020 | Immune The... | - | - | - | connect.or... |
19.05.2020 | Immune The... | - | - | - | connect.or... |
19.05.2020 | Immune The... | - | - | - | connect.or... |
Show more